Lumos Pharma Inc.

4.34
0.00 (0.00%)
At close: Dec 11, 2024, 9:00 PM

Lumos Pharma Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08
Cash & Equivalents 35.08M 56.01M 94.81M 98.68M 90.55M 120.74M 158.71M 131.49M 195.62M 190.4M 61.29M 20.25M 39.49M 10.57M 15.22M 6.28M
Short-Term Investments 999K 11.35M n/a n/a n/a n/a n/a n/a 2.18M 12.39M 249K 1.49M 2.49M 2.27M n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a 140K 140K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets n/a -283K -635K -584K n/a n/a n/a n/a n/a -15.6M n/a n/a n/a n/a 850K 850K
Receivables 210K 223K 128K 26.26M 35K 798K 10.53M 30.5M 5.39M n/a 1.66M 738K 399K 842K 1.58M 595K
Inventory n/a n/a n/a n/a n/a n/a n/a n/a -5.39M 3.73M n/a -738K 409K n/a 110K 50K
Other Current Assets 3.75M 4.43M 4.74M 3.51M 82K 11.07M 12.45M 5.92M 4.95M 8.33M 773K 907K 409K 959K 110K 1.9M
Total Current Assets 40.03M 72.01M 99.68M 128.45M 94.42M 127.07M 175.47M 167.91M 208.14M 230.46M 63.97M 23.39M 42.79M 14.64M 18.9M 8.77M
Property-Plant & Equipment 603K 283K 635K 584K 2.37M 3.73M 5.09M 6.83M 10.4M 7.6M 6.59M 6.04M 5.59M 5.44M 2.92M 955K
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 603K 283K 635K 584K 2.37M 3.87M 5.23M 6.83M 10.4M 7.6M 6.59M 6.04M 5.59M 5.44M 3.77M 1.8M
Total Assets 40.64M 72.29M 100.31M 129.03M 96.79M 130.94M 180.7M 174.75M 218.54M 238.06M 70.56M 29.43M 48.38M 20.08M 22.67M 10.58M
Account Payables 890K 275K 612K 244K 365K 555K 9.26M 22.88M 3.66M 2.41M 612K 972K 1.67M 552K 1.08M 601K
Deferred Revenue n/a n/a n/a n/a n/a n/a 56K 391K 892K 12.97M 84K 84K n/a 951K 947K 1.24M
Short-Term Debt 564K 466K 704K 638K 232K 61K -12.31M -14.08M 584K 227K 189K 204K 6.21M 207K 35K 4K
Other Current Liabilities 5.58M 5.97M 3.81M 5.58M 655K 8.23M 12.56M 14.4M 8.84M 9.42M 2.76M 1.66M 2.78M 1.55M 1.18M 1.24M
Total Current Liabilities 7.03M 6.71M 5.13M 6.46M 11.83M 8.85M 22.03M 37.91M 14.84M 25.1M 3.88M 2.92M 10.66M 3.27M 3.24M 1.85M
Long-Term Debt 303K n/a 205K n/a 191K 43K 111K 285K -785K -297K 1.08M 1.18M 942K 7.09M 6.08M 6M
Other Long-Term Liabilities 6M n/a 6M n/a 63.53M 6.91M 7M 7.09M 6M 6M 5.95M 6M n/a 61.74M 54.13M 34.55M
Total Long-Term Liabilities 6.3M 6M 6.21M 6M 6.08M 6.95M 7.11M 7.38M 7.93M 9.18M 8.35M 8.58M 942K 68.83M 60.21M 40.56M
Total Liabilities 13.33M 12.71M 11.34M 12.46M 17.91M 15.8M 29.14M 45.28M 22.77M 34.28M 12.23M 11.5M 11.61M 72.1M 63.45M 42.41M
Total Debt 585K 233K 557K 319K 1.23M 104K 111K 285K 368K 860K 7.03M 7.18M 7.16M 7.29M 6.11M 6.01M
Common Stock 81K 82K 83K 83K 374K 373K 372K 292K 288K 280K 266K 210K 206K 36K 67K 66K
Retained Earnings -161.52M -127.48M -96.42M -65.99M -334M -291.01M -237.46M -165.51M -80.35M -33.12M -135.98M -104.8M -81.48M -63.39M -46.96M -37.52M
Comprehensive Income -0.00 -9K 0.00 -129.03M -63.53M -6.99M -6.64M -5.73M -6.52M n/a n/a n/a n/a -2.22M -1.57M -1.27M
Shareholders Equity 27.3M 59.58M 88.98M 116.57M 78.88M 115.14M 151.56M 129.47M 195.77M 203.78M 58.33M 17.93M 36.77M -54.96M -43.14M -34.37M
Total Investments 999K 11.35M n/a n/a n/a 140K 140K n/a 2.18M 12.39M 249K 1.49M 2.49M 2.27M n/a n/a